Sinovac Biotech's total assets for Q4 2023 were $13.66B, a decrease of -3.23% from the previous quarter. SVA total liabilities were $1.64B for the fiscal quarter, a 16.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.